Needle-safe rules safer still in Germany:
This article was originally published in Clinica
Executive Summary
Germany's technical regulation for biological materials, the so-called TRBA 250, has been strengthened again in a bid to provide maximum safety to staff who are exposed to needlestick injuries. The regulation has so far allowed employers to keep non-needle safe devices in circulation, provided that their other working practices guaranteed a minimisation of the risk of a sharps injury (see Clinica No 1266, p 6). Now, and with obvious implications for providers of autodisable devices, the federal workers' protection and medical staff institute (BAA) has decided that only safe devices can be used - except in patients who have a known negative disease status and from whom no blood-borne disease can be contracted. The view of the German accident insurance group (DGU) is that even routine blood draws should be done with needle-safe devices, obviating the need for hospitals to carry two device types.
You may also be interested in...
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.